Search

everythinglearnresearchcommunity

for

Search:↓

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

People with vitiligo or alopecia areata have higher anxiety and depression than healthy people.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Hair regrowth improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Women with PCOS often have sleep and mental health issues, especially if overweight or insulin resistant.

Finasteride may cause slight depression and anxiety.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Vitiligo's impact varies widely, affecting both emotions and social life, not just physical symptoms.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Many dermatology patients experienced anxiety, depression, PTSD, and skin issues after the February 6, 2023 earthquakes, highlighting the need for combined skin and mental health care.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.